Kamada Ltd.
- KMDA
- NASDAQ
- Drug Manufacturers - Specialty & Generic
- Plasma-Derived Therapies
- Specialty Pharmaceuticals
$7.66
Today −1.29%Quote Oct 19, 2026, 04:58 PM UTC
−10.50%over the last month
Max drawdown −14.3%From 1-month high −12.5%3 months +9.4%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Kamada
Kamada Ltd. is a biopharmaceutical firm focused on developing, manufacturing, and distributing protein therapeutics derived from human plasma. The company operates through two core business areas: its proprietary product segment and its distribution division.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Employees
462
Market value
$441.9M
Quote Oct 19
Analyst target
$15.00
+95.8% from here
Floor
$7.43
3.0% below price
Resistance
$7.75
1.2% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about KMDAPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free